RFS Pharma's Merger

RFS Pharma raised a round of funding on November 25, 2014. Investors include Cocrystal Pharma.

RFS Pharma is a bio-pharmaceutical company focused on developing novel, differentiated therapeutics for the treatment of hepatitis viruses and emerging viruses. With products currently under developme…

Articles about RFS Pharma's Merger: